JP2015534990A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015534990A5 JP2015534990A5 JP2015538124A JP2015538124A JP2015534990A5 JP 2015534990 A5 JP2015534990 A5 JP 2015534990A5 JP 2015538124 A JP2015538124 A JP 2015538124A JP 2015538124 A JP2015538124 A JP 2015538124A JP 2015534990 A5 JP2015534990 A5 JP 2015534990A5
- Authority
- JP
- Japan
- Prior art keywords
- aryl
- group
- alkyl
- amino
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261716987P | 2012-10-22 | 2012-10-22 | |
| US61/716,987 | 2012-10-22 | ||
| US201261735458P | 2012-12-10 | 2012-12-10 | |
| US61/735,458 | 2012-12-10 | ||
| PCT/US2013/066041 WO2014066304A1 (en) | 2012-10-22 | 2013-10-22 | Compositions and methods for treating or preventing diseases or disorders associated with misregulated eif4e |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015534990A JP2015534990A (ja) | 2015-12-07 |
| JP2015534990A5 true JP2015534990A5 (enExample) | 2016-12-08 |
Family
ID=50545165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015538124A Pending JP2015534990A (ja) | 2012-10-22 | 2013-10-22 | 誤制御されたｅＩＦ４Ｅに関連する疾患又は障害を治療又は予防するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9409901B2 (enExample) |
| EP (1) | EP2909203A4 (enExample) |
| JP (1) | JP2015534990A (enExample) |
| AU (1) | AU2013334860B2 (enExample) |
| CA (1) | CA2888889A1 (enExample) |
| IL (1) | IL238415B (enExample) |
| WO (1) | WO2014066304A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6707630B2 (ja) * | 2015-06-01 | 2020-06-10 | バンタム、ファーマシューティカル、リミテッド、ライアビリティー、カンパニーＢａｎｔａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌ， Ｌｌｃ | 置換ピラゾールおよびピロール化合物、および翻訳開始の阻害およびこれらに関連する疾患および障害の治療のためにこれらを用いる方法 |
| EP3548482A4 (en) | 2016-11-30 | 2020-08-19 | Bantam Pharmaceutical, LLC | SUBSTITUTED PYRAZOLE COMPOUNDS AND THEIR METHODS OF USE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES |
| US12150934B2 (en) | 2016-11-30 | 2024-11-26 | Bantam Pharmaceutical, Llc | Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases |
| CA3126070A1 (en) * | 2019-09-03 | 2021-03-11 | Sovargen Co., Ltd. | Composition for diagnosing or treating conditions associated with increased elf4e activity comprising elf4e inhibitor |
| WO2021067752A1 (en) * | 2019-10-04 | 2021-04-08 | Yale University | Targeting cap-dependent translation to reduce seizures in mtor disorders |
| AU2021230289A1 (en) * | 2020-03-03 | 2022-09-29 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5324718A (en) | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
| US5472954A (en) | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
| WO2005103022A1 (en) * | 2004-04-20 | 2005-11-03 | Transtech Pharma, Inc. | Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| JP5225691B2 (ja) * | 2005-01-21 | 2013-07-03 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | タンパク質合成の調節 |
| GB0614068D0 (en) * | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| GB0614070D0 (en) | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| PE20080928A1 (es) * | 2006-10-31 | 2008-08-15 | Schering Corp | Derivados de anilinopiperazina como inhibidores de proteina quinasa |
| EP2182986A2 (en) * | 2007-07-31 | 2010-05-12 | Schering Corporation | Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment |
| JP2013533258A (ja) | 2010-06-28 | 2013-08-22 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 細胞増殖を阻害するための化合物 |
-
2013
- 2013-10-22 CA CA2888889A patent/CA2888889A1/en not_active Abandoned
- 2013-10-22 AU AU2013334860A patent/AU2013334860B2/en not_active Ceased
- 2013-10-22 EP EP13849178.2A patent/EP2909203A4/en not_active Withdrawn
- 2013-10-22 US US14/437,251 patent/US9409901B2/en not_active Expired - Fee Related
- 2013-10-22 JP JP2015538124A patent/JP2015534990A/ja active Pending
- 2013-10-22 WO PCT/US2013/066041 patent/WO2014066304A1/en not_active Ceased
-
2015
- 2015-04-21 IL IL238415A patent/IL238415B/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016528301A5 (enExample) | ||
| JP2015534990A5 (enExample) | ||
| EA025086B9 (ru) | Производные индоламида и родственные соединения для использования при лечении нейродегенеративных заболеваний | |
| NZ708593A (en) | Novel pyrazole derivative | |
| EA201890146A1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ СОЛИДНЫХ ОПУХОЛЕЙ С ИСПОЛЬЗОВАНИЕМ КОМБИНИРОВАННОЙ ТЕРАПИИ ИНГИБИТОРОМ mTOR В ВИДЕ НАНОЧАСТИЦ | |
| UA109698C2 (xx) | Похідні азаіндазолу або діазаіндазолу як медикамент | |
| EA201391486A1 (ru) | Способы и композиции для лечения болезни паркинсона | |
| BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
| PH12014500472A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| PH12014502218A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| EP4227304A3 (en) | Thiadiazole analogs and their use for treating diseases associated with a deficiency of smn motor neurons | |
| EP4663636A3 (en) | Trifluoromethyl substituted pyrazoles as human plasma kallikrein inhibitors | |
| WO2014144130A3 (en) | Pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of use thereof | |
| EP4275748A3 (en) | Compositions and methods for treating cns disorders | |
| UA109991C2 (xx) | Карбаматні сполуки, їх отримання і застосування | |
| PH12014500239A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| EA201391485A1 (ru) | Способы и композиции для лечения нейродегенеративных заболеваний | |
| MX2021011563A (es) | Derivados de 2,3-dihidro-isoindol-1-ona, como inhibidores de la btk quinasa y composiciones farmaceuticas que los incluyen. | |
| PH12014500371A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| PH12015501942A1 (en) | Susbtituted 3-phenylpropylamine derivatives for the treatment of opthalmic diseases and disorders | |
| JP2014513136A5 (enExample) | ||
| NZ708526A (en) | Novel rock inhibitors | |
| IN2014DN05869A (enExample) | ||
| WO2015104292A3 (en) | Compounds for use in treating or preventing cancerous diseases |